Venture

Osteoarthritis (OA) is the most common form of arthritis and the leading cause of disability in adults and the aging population. There is no cure for OA. ArthriC is enteric-coated capsules containing compounds identified from a generally regarded as safe pool which target a novel OA disease modifying target.  Preclinical studies showed oral administration of ArthriC exerted not only disease-improvement, but also a disease-preventive (delays disease initiation), and palliative effect on OA.

ArthriC Team:

Daniel Leong